Innovation in Neuroimaging: Unlocking the Mysteries of the Brain
Emerging technology gives radiologists an unprecedented view of the brain.
Use of PET Changes Clinical Diagnosis for Some Patients with Dementia
PET with [18 F]flutemetamol can assist physicians in early and more accurate diagnosis of early onset dementia.
PET Helps Predict Progression from MCI to Alzheimer’s Disease
Brain PET and age may help clinicians determine which patients with amnestic mild cognitive disorder may progress on to probable Alzheimer’s disease.
13N-PET/MRI Detects Signs of Coronary Artery Disease
Cardiac imaging with PET and MRI shows excellent diagnostic accuracy compared with SPECT-MPI.
Rheumatoid Arthritis Inflammation Visualized with PET and SPECT
Imaging visualizes rheumatoid arthritis inflammation in preclinical study.
18F-FDG/PET Helps Predict Prognosis of Vegetative Patients
18F-FDG PET more accurate than fMRI and may help physicians better determine the long-term recovery of patients with unresponsive wakefulness syndrome.
FDA Approves ResolutionMD for Diagnosis on Mobile Devices
Calgary Scientific’s ResolutionMD received FDA clearance for diagnosis on mobile devices for most imaging modalities.
By clicking Accept, you agree to become a member of the UBM Medica Community.